SEC Form 4 · accession 0001209191-17-067091
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
A J Kazimi
Officer — Chairman and CEO · Director · 10% Owner
Period of report
Dec 22, 2017
Accepted (ET)
Dec 22, 2017 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 22, 2015 | G | 15,000 | $0.00 | D | 5,830,270 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction is a charitable donation